These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 28064229)

  • 1. Outcomes After Radio(chemo)therapy for Non-Metastatic Bile Duct Cancer.
    Bolm L; Kaesmann L; Bartscht T; Schild SE; Rades D
    In Vivo; 2017 Jan; 31(1):117-120. PubMed ID: 28064229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
    Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
    J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.
    Rades D; Schulte R; Yekebas EF; Homann N; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Jan; 183(1):10-6. PubMed ID: 17225940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - results of a matched-pair analysis.
    Rades D; Schroeder U; Bajrovic A; Schild SE
    Eur J Cancer; 2011 Dec; 47(18):2729-34. PubMed ID: 21726998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram prediction of survival and recurrence in patients with extrahepatic bile duct cancer undergoing curative resection followed by adjuvant chemoradiation therapy.
    Song C; Kim K; Chie EK; Kim JH; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):499-504. PubMed ID: 24074923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
    Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
    Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery.
    Park HJ; Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Anticancer Res; 2014 Nov; 34(11):6685-90. PubMed ID: 25368275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage radiation therapy for isolated local recurrence of extrahepatic cholangiocarcinoma after radical surgery: a retrospective study.
    Kim SW; Lim DH; Park HC; Park W; Park JO; Park YS
    Ann Surg Oncol; 2015 Apr; 22(4):1308-14. PubMed ID: 25319582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma.
    Nelson JW; Ghafoori AP; Willett CG; Tyler DS; Pappas TN; Clary BM; Hurwitz HI; Bendell JC; Morse MA; Clough RW; Czito BG
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):148-53. PubMed ID: 18805651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease recurrence patterns and analysis of clinicopathological prognostic factors for recurrence after resection for distal bile duct cancer.
    Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Kim JS; Suh SO; Choi SY
    Am Surg; 2015 Mar; 81(3):289-96. PubMed ID: 25760206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of adjuvant radiation therapy for microscopic residual tumor after resection of extrahepatic bile duct cancer.
    Matsuda T; Fujita H; Harada N; Kunimoto Y; Tanaka T; Kimura T; Kitaoka H; Asano E; Hosono M; Hayashi T; Ogino K
    Am J Clin Oncol; 2013 Oct; 36(5):461-5. PubMed ID: 22706178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy for gallbladder and bile duct cancers: retrospective comparative study.
    Tugba Kos F; Aksoy S; Odabas H; Ozdemir N; Oksuzoglu B; Uncu D; Zengin N
    J BUON; 2011; 16(3):464-8. PubMed ID: 22006751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent involved-field radiotherapy and XELOX versus XELOX chemotherapy alone in gastric cancer patients with postoperative locoregional recurrence.
    Yuan ST; Wang FL; Liu N; Liu YH; Liu SG; Huang Y; Li YQ; Liu XB; Zhang Y; Li WH; Yu J; Zhang JD
    Am J Clin Oncol; 2015 Apr; 38(2):130-4. PubMed ID: 23608834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemo-radiotherapy in ampullary cancers.
    Sikora SS; Balachandran P; Dimri K; Rastogi N; Kumar A; Saxena R; Kapoor VK
    Eur J Surg Oncol; 2005 Mar; 31(2):158-63. PubMed ID: 15698732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative radio/chemo-radiotherapy in combination with intraoperative radiotherapy for T3-4Nx rectal cancer.
    Sadahiro S; Suzuki T; Ishikawa K; Fukasawa M; Saguchi T; Yasuda S; Makuuchi H; Murayama C; Ohizumi Y
    Eur J Surg Oncol; 2004 Sep; 30(7):750-8. PubMed ID: 15296989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction Chemotherapy and Sequential Concomitant Chemo-radiation in Locally Advanced Head and Neck Cancers: How Induction-phase Intensity and Treatment Breaks May Impact on Clinical Outcomes.
    Franco P; Potenza I; Schena M; Riva G; Pecorari G; Garzino Demo P; Fasolis M; Moretto F; Garzaro M; Di Muzio J; Melano M; Airoldi M; Ragona R; Rampino M; Ricardi U
    Anticancer Res; 2015 Nov; 35(11):6247-54. PubMed ID: 26504058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome.
    Hurmuzlu M; Monge OR; Smaaland R; Viste A
    Dis Esophagus; 2010 Apr; 23(3):244-52. PubMed ID: 19664075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.